The French agency for veterinary medicinal products (ANMV), within ANSES, relies on two tools for monitoring antimicrobial uses in veterinary medicine:

• the national monitoring of sales of veterinary medicinal products containing antimicrobials, which has been in place since 1999 and allows the annual collection of sales volumes from marketing authorisation holders (MAHs),
• the national monitoring of antimicrobial use based on mandatory reporting of all antimicrobial cessions by veterinarians, pharmacists, manufacturers and distributors of medicated feed via the CalypsoVet platform.

These two follow-ups are complementary and make it possible to assess the use of antimicrobials and to monitor the evolution of antibiotic therapy practices for the different animal species. The information collected is one of the essential elements, together with the bacterial resistance monitoring systems, to enable an assessment of the risks associated with antibiotic resistance.

In addition, the ANMV analyses the risks associated with antimicrobial resistance in the context of marketing authorisation procedures. The Agency is also working on the evaluation of risky practices in veterinary medicine and on possible alternatives to the use of antibiotics on farms.

Finally, ANMV is involved in national, European and international reflections on the collection of data on sales and uses of antimicrobials, on the One Health risk assessment for antimicrobial resistance and on integrated surveillance allowing the analysis of the links between uses and resistance to antibiotics.

The different areas of activity of the ANMV antibiotic resistance department: